• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性缺血性脑卒中患者颈动脉粥样硬化与脂蛋白(a)的关系

Relationship between carotid atherosclerosis and lipoprotein (a) in patients with acute ischemic stroke.

作者信息

Zhao Yongna, Wang Zhichao, Ji Ruijun, Wang Yongjun, Zhang Yaguang, Yu Kai

机构信息

Department of Neurology, Renqiu Kangji Hospital, Renqiu, China.

Department of Neurology, Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing, China.

出版信息

Front Neurol. 2024 Jun 26;15:1383771. doi: 10.3389/fneur.2024.1383771. eCollection 2024.

DOI:10.3389/fneur.2024.1383771
PMID:38988596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11234851/
Abstract

OBJECTIVE

This study aimed to examine the relationship between lipoprotein (a) (Lp[a]) and other blood lipid indexes and carotid artery atherosclerosis in patients with acute ischemic stroke (AIS).

METHODS

A total of 2,018 patients were selected from the hospital "acute stroke intervention and secondary prevention registration database" by identifying blood fat indexes (cholesterol, triglyceride, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and Lp[a]). Based on the results of carotid artery ultrasound examinations, the patients were divided into a "no plaque" group, comprising 400 patients, a "plaque and no stenosis" group, comprising 1,122 patients and a "carotid stenosis" group, comprising 496 patients. The relationship between Lp(a) and blood lipid indexes and carotid artery atherosclerosis was then investigated using multi-factor logistics regression analysis.

RESULTS

There were 400 patients (19.8%) with no carotid plaque, 1,122 patients (55.6%) with plaque and no carotid stenosis and 496 patients (24.6%) with carotid stenosis. As the degree of carotid artery atherosclerosis increased, the Lp(a) level gradually increased; Lp(a) and cholesterol were identified as independent risk factors for carotid atherosclerosis.

CONCLUSION

Lipoprotein (a) and cholesterol are independent risk factors for patients with AIS with carotid atherosclerosis, and their levels increase with the degree of carotid artery atherosclerosis; therefore, attention should focus on levels of cholesterol and Lp(a) in acute stroke patients to control atherosclerosis effectively.

摘要

目的

本研究旨在探讨急性缺血性卒中(AIS)患者脂蛋白(a)[Lp(a)]与其他血脂指标及颈动脉粥样硬化之间的关系。

方法

从医院“急性卒中干预与二级预防登记数据库”中选取2018例患者,检测其血脂指标(胆固醇、甘油三酯、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇和Lp(a))。根据颈动脉超声检查结果,将患者分为“无斑块”组(400例)、“有斑块但无狭窄”组(1122例)和“颈动脉狭窄”组(496例)。然后采用多因素logistic回归分析研究Lp(a)与血脂指标及颈动脉粥样硬化之间的关系。

结果

400例患者(19.8%)无颈动脉斑块,1122例患者(55.6%)有斑块但无颈动脉狭窄,496例患者(24.6%)有颈动脉狭窄。随着颈动脉粥样硬化程度的增加,Lp(a)水平逐渐升高;Lp(a)和胆固醇被确定为颈动脉粥样硬化的独立危险因素。

结论

脂蛋白(a)和胆固醇是AIS合并颈动脉粥样硬化患者的独立危险因素,且其水平随颈动脉粥样硬化程度的增加而升高;因此,应关注急性卒中患者的胆固醇和Lp(a)水平,以有效控制动脉粥样硬化。

相似文献

1
Relationship between carotid atherosclerosis and lipoprotein (a) in patients with acute ischemic stroke.急性缺血性脑卒中患者颈动脉粥样硬化与脂蛋白(a)的关系
Front Neurol. 2024 Jun 26;15:1383771. doi: 10.3389/fneur.2024.1383771. eCollection 2024.
2
The value of Lp(a) and TG/HDLC in peripheral blood to assess the stability of carotid plaque in patients with ischemic stroke.外周血中脂蛋白(a)及甘油三酯与高密度脂蛋白胆固醇比值评估缺血性脑卒中患者颈动脉斑块稳定性的价值
Brain Behav. 2024 Jan;14(1):e3355. doi: 10.1002/brb3.3355.
3
Non-traditional lipid parameters as potential predictors of carotid plaque vulnerability and stenosis in patients with acute ischemic stroke.非传统脂质参数作为急性缺血性脑卒中患者颈动脉斑块易损性和狭窄的潜在预测指标。
Neurol Sci. 2023 Mar;44(3):835-843. doi: 10.1007/s10072-022-06472-3. Epub 2022 Oct 27.
4
A retrospective study of immunoglobulin E as a biomarker for the diagnosis of acute ischemic stroke with carotid atherosclerotic plaques.一项关于免疫球蛋白 E 作为颈动脉粥样硬化斑块性急性缺血性脑卒中生物标志物的回顾性研究。
PeerJ. 2022 Oct 26;10:e14235. doi: 10.7717/peerj.14235. eCollection 2022.
5
Association between carotid intima media thickness and small dense low-density lipoprotein cholesterol in acute ischaemic stroke.颈动脉内膜中层厚度与急性缺血性脑卒中小而密低密度脂蛋白胆固醇的关系。
Lipids Health Dis. 2020 Jul 28;19(1):177. doi: 10.1186/s12944-020-01353-0.
6
Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease.脂蛋白(a)血清浓度和载脂蛋白(a)表型与缺血性脑血管疾病的严重程度和存在情况相关。
Stroke. 1995 Oct;26(10):1841-8. doi: 10.1161/01.str.26.10.1841.
7
Clinical Utility of the Serum Level of Lipoprotein-Related Phospholipase A2 in Acute Ischemic Stroke With Cerebral Artery Stenosis.血清脂蛋白相关磷脂酶A2水平在伴有脑动脉狭窄的急性缺血性卒中中的临床应用
Front Neurol. 2021 Mar 4;12:642483. doi: 10.3389/fneur.2021.642483. eCollection 2021.
8
[Association of lipoprotein (a) with ischemic stroke and stenotic carotid atherosclerosis].脂蛋白(a)与缺血性卒中及颈动脉狭窄性动脉粥样硬化的关联
Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(3. Vyp. 2):42-48. doi: 10.17116/jnevro202012003242.
9
Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Carotid Magnetic Resonance Imaging Substudy-Brief Report.脂蛋白(a)(Lp(a))水平可预测强化降脂治疗的动脉粥样硬化性心血管疾病患者颈动脉粥样硬化进展:AIM-HIGH(代谢综合征伴低 HDL/高甘油三酯患者的动脉粥样血栓形成干预:对全球健康结局的影响)颈动脉磁共振成像子研究简要报告。
Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):673-678. doi: 10.1161/ATVBAHA.117.310368. Epub 2018 Jan 4.
10
[The association between carotid atherosclerosis and ischemic stroke in patients with nonvalvular atrial fibrillation].[非瓣膜性心房颤动患者颈动脉粥样硬化与缺血性卒中的关联]
Zhonghua Nei Ke Za Zhi. 2020 Apr 1;59(4):292-296. doi: 10.3760/cma.j.cn112138-20190425-00324.

引用本文的文献

1
Lipoprotein(a) as a Stroke Biomarker: Pathophysiological Pathways and Therapeutic Implications.脂蛋白(a)作为一种中风生物标志物:病理生理途径及治疗意义
J Clin Med. 2025 Apr 25;14(9):2990. doi: 10.3390/jcm14092990.
2
Synergistic effects of lipoprotein (a) and fibrinogen on carotid plaque in patients with coronary artery disease.脂蛋白(a)与纤维蛋白原对冠心病患者颈动脉斑块的协同作用。
Eur J Med Res. 2025 Feb 24;30(1):129. doi: 10.1186/s40001-025-02351-7.
3
Lipoprotein (a) as a Cardiovascular Risk Factor in Controversial Clinical Scenarios: A Narrative Review.脂蛋白(a)作为有争议的临床情况下的心血管风险因素:一个叙述性综述。
Int J Mol Sci. 2024 Oct 14;25(20):11029. doi: 10.3390/ijms252011029.

本文引用的文献

1
The correlation between lipoprotein(a) elevations and the risk of recurrent cardiovascular events in CAD patients with different LDL-C levels.不同低密度脂蛋白胆固醇(LDL-C)水平的冠心病(CAD)患者中脂蛋白(a)升高与心血管事件复发风险之间的相关性。
BMC Cardiovasc Disord. 2022 Apr 15;22(1):171. doi: 10.1186/s12872-022-02618-5.
2
Lipoprotein(a): a risk factor for atherosclerosis and an emerging therapeutic target.脂蛋白(a):动脉粥样硬化的危险因素和新兴治疗靶点。
Heart. 2022 Dec 13;109(1):18-25. doi: 10.1136/heartjnl-2021-320708.
3
Association of Viral Persistence and Atherosclerosis in Adults With Treated HIV Infection.成人 HIV 感染者病毒持续存在与动脉粥样硬化的关系。
JAMA Netw Open. 2020 Oct 1;3(10):e2018099. doi: 10.1001/jamanetworkopen.2020.18099.
4
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases.中国卒中学会脑血管病临床管理指南:执行摘要及 2019 年缺血性脑血管病临床管理更新。
Stroke Vasc Neurol. 2020 Jun;5(2):159-176. doi: 10.1136/svn-2020-000378. Epub 2020 Jun 18.
5
Positive Influence of Stroke Health Manager on Risk Factors Control and Medication Adherence After Ischemic Stroke.卒中健康管理师对缺血性卒中后危险因素控制及药物依从性的积极影响
Front Neurol. 2020 Mar 11;11:168. doi: 10.3389/fneur.2020.00168. eCollection 2020.
6
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.脂蛋白(a)降低与心血管疾病患者。
N Engl J Med. 2020 Jan 16;382(3):244-255. doi: 10.1056/NEJMoa1905239. Epub 2020 Jan 1.
7
Looking at Lp(a) and Related Cardiovascular Risk: from Scientific Evidence and Clinical Practice.关注脂蛋白(a)及其相关心血管风险:从科学证据到临床实践。
Curr Atheroscler Rep. 2019 Jul 27;21(10):37. doi: 10.1007/s11883-019-0803-9.
8
Elevated Lipoprotein(a) and Risk of Ischemic Stroke.脂蛋白(a)升高与缺血性脑卒中风险。
J Am Coll Cardiol. 2019 Jul 9;74(1):54-66. doi: 10.1016/j.jacc.2019.03.524.
9
Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering Therapy.脂蛋白(a)颗粒生成作为不同载脂蛋白(a)亚型大小和背景降脂治疗时血浆脂蛋白(a)浓度的决定因素。
J Am Heart Assoc. 2019 Apr 2;8(7):e011781. doi: 10.1161/JAHA.118.011781.
10
Dietary natural products as emerging lipoprotein(a)-lowering agents.膳食天然产物作为新兴的脂蛋白(a)降低剂。
J Cell Physiol. 2019 Aug;234(8):12581-12594. doi: 10.1002/jcp.28134. Epub 2019 Jan 13.